Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (281-290 of 461) with videos related to

Pageof 47
Sort By:
The International Journal of Neuropsychopharmacology|January 27, 2004
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, et al.
Internal Medicine (Tokyo, Japan)|June 10, 2003
Preclinical Cushing's syndrome presenting with isolated adrenocorticotropin (ACTH) deficiency-like manifestations and severe hypoalbuminemia without overt adrenal masses in a patient with Chilaiditi syndrome and mental retardationKeiichi Ikeda, Masato Mizuguchi, Toshihiro Ebisawa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialShinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Psychiatry Research|March 21, 2012
Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendationTakefumi Suzuki, Gary Remington, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 2, 2008
Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in JapanHiroyuki Uchida, Takefumi Suzuki, David C Mamo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 17, 2013
Factor structure of the targeted inventory on problems in schizophreniaShoji Tanaka, Takanori Nagase, Takefumi Suzuki, et al.
Psychiatry and Clinical Neurosciences|December 28, 2018
Etiology of out-of-hospital cardiac arrest in psychiatric patients: Chart reviewTakuto Ishida, Kazuki Miyazaki, Takahiro Yukawa, et al.
Biological & Pharmaceutical Bulletin|January 5, 2016
Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in RatsRyo Kawashima, Masaki Uchida, Tsutomu Yamaki, et al.
Physical Chemistry Chemical Physics : PCCP|October 27, 2006
Particle-size effect of nanoscale platinum catalysts in oxygen reduction reaction: an electrochemical and 195Pt EC-NMR studyHiroshi Yano, Junji Inukai, Hiroyuki Uchida, et al.
Pageof 47

Showing results (281-290 of 461) with videos related to

Sort By:
Pageof 47
The International Journal of Neuropsychopharmacology|January 27, 2004
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, et al.
Internal Medicine (Tokyo, Japan)|June 10, 2003
Preclinical Cushing's syndrome presenting with isolated adrenocorticotropin (ACTH) deficiency-like manifestations and severe hypoalbuminemia without overt adrenal masses in a patient with Chilaiditi syndrome and mental retardationKeiichi Ikeda, Masato Mizuguchi, Toshihiro Ebisawa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trialShinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry|October 19, 2017
Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD DataChisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al.
Psychiatry Research|March 21, 2012
Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendationTakefumi Suzuki, Gary Remington, Benoit H Mulsant, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 2, 2008
Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in JapanHiroyuki Uchida, Takefumi Suzuki, David C Mamo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 17, 2013
Factor structure of the targeted inventory on problems in schizophreniaShoji Tanaka, Takanori Nagase, Takefumi Suzuki, et al.
Psychiatry and Clinical Neurosciences|December 28, 2018
Etiology of out-of-hospital cardiac arrest in psychiatric patients: Chart reviewTakuto Ishida, Kazuki Miyazaki, Takahiro Yukawa, et al.
Biological & Pharmaceutical Bulletin|January 5, 2016
Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in RatsRyo Kawashima, Masaki Uchida, Tsutomu Yamaki, et al.
Physical Chemistry Chemical Physics : PCCP|October 27, 2006
Particle-size effect of nanoscale platinum catalysts in oxygen reduction reaction: an electrochemical and 195Pt EC-NMR studyHiroshi Yano, Junji Inukai, Hiroyuki Uchida, et al.
Pageof 47